Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.

T L Yue; L Vickery-Clark; C S Louden; J L Gu; X L Ma; P K Narayanan; X Li; J Chen; B Storer; R Willette

doi:10.1161/01.cir.102.suppl_3.iii-281

Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.

Identifier:nobleid.org/w1/20260515/6AF124EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6AF124EB.svg?ark=w1%2F20260515%2F6AF124EB)](https://nobleid.org/work/w1/20260515/6AF124EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.

Identifier:nobleid.org/w1/20260515/6AF124EB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6AF124EB.svg?ark=w1%2F20260515%2F6AF124EB)](https://nobleid.org/work/w1/20260515/6AF124EB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work